Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
IMAS Announces Dr Scott Gottlieb as Keynote Speaker for ACCESS 2023 in Miami Beach
BOULDER, Colo., Dec. 8, 2022 /PRNewswire/ — The International Market Access Society (IMAS) is pleased to announce Dr Scott Gottlieb, Physician, Former FDA Commissioner, and Former CMS Senior Advisor, as the opening keynote speaker on April 4, 2023, for the ACCESS 2023 Annual Meeting & Expo in Miami Beach.
Dr Gottlieb will deliver an in-person keynote address on Healthcare Innovation and Affordability – Are They Compatible? He is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.
Over 400 market access professionals and stakeholders are expected to attend ACCESS 2023 at the Fontainebleau Miami Beach on April 3-5, the leading event in the US for leaders and stakeholders to shape the future of market access, pricing, and reimbursement.
Sessions will cover 5 major topic areas, over 2 days of plenary sessions, interactive workshops, engaging debate panels and oral presentations, including:
- Optimal Market Access: Role of Real-World Evidence
- Payer Strategies and the Changing Impact of Legislative Policies on Market Access
- Patient Perspective and Role in Policy Decision Making – Imaginary or Real Influence?
- Access Evolution in Low- and Middle-income Countries
- The Latest and Most Important Access Methodologies, Frameworks, and Trends
For the latest agenda and confirmed speakers for ACCESS 2023, visit www.marketaccess.org/access2023. Super early bird rates are now in effect, with registration starting as low as $600.
Relevant and recent posts
Dr. Sanjay Gupta: Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay…
Thought Leader: Sanjay Gupta
Peter Zeihan: The Geopolitics of Climate Change
From Peter Zeihan: With a glacier as the backdrop for this video, I figured it only appropriate to discuss resource exploitation, Arctic shipping, and agriculture…
Thought Leader: Peter Zeihan
More with this speaker
Dr. Scott Gottlieb on Trump 2.0
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb to keynote MM+M Transform in April
Thought Leader: Scott Gottlieb